Total synthesis of azumamides A and E

Angewandte Chemie - International Edition

Volumn 45, Issue 45, 2006, Pages 7557-7560

  Izzo, Irene ^a   Maulucci, Nakia ^a   Bifulco, Giuseppe ^a   De Riccardis, Francesco ^a  

^a UNIVERSITY OF SALERNO   (Italy)

Author keywords

Inhibitors; Macrolactamization; Natural products; Peptides; Total synthesis

Indexed keywords

ENZYME INHIBITION; MARINE BIOLOGY; POLYPEPTIDES; STEREOCHEMISTRY;

AZUMAMIDES; MACROLACTAMIZATION; NATURAL PRODUCTS;

SYNTHESIS (CHEMICAL);

AZUMANIDE A; AZUMANIDE E; BIOLOGICAL FACTOR; CYCLOPEPTIDE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

BIOLOGICAL FACTORS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; PEPTIDES, CYCLIC;

EID: 33845202563     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200602033     Document Type: Article

References (26)

1. For recent reviews, see: J. W. Blunt, B. R. Copp, M. H. G. Munro, P. T. Northcote, M. R. Prinsep, Nat. Prod. Rep. 2006, 23, 26-78, and references therein.
2. For recent reviews, see: Y. Hamada, T. Shiori, Chem. Rev. 2005, 105, 4441-4482, and references therein.
3. Y. Nakao, S. Yoshida, S. Matsunaga, N. Shindoh, Y. Terada, K. Nagai, J. K. Yamashita, A. Ganesan, R. W. M. van Soest, N. Fusetani, Angew. Chem., DOI: 10.1002/ange.200602047;
4. Angew. Chem. Int. Ed., DOI: 10.1002/anie.200602047.
5. a) S. Minucci, P.G. Pelicci, Nat. Rev. Cancer 2006, 6, 38-51;
6. b) M. Biel, V. Washolowski, A. Giannis, Angew. Chem. 2005, 117, 3248-3280;
7. Angew. Chem. Int. Ed. 2005, 44, 3186-3216;
8. c) T. A. Miller, D. J. Witter, S. Belvedere, J. Med. Chem. 2003, 46, 5097-5116; note that the HDAC inhibition profiles observed for azumamides E and C contradict the assumption that carboxylic acids at the "zinc binding" domain give poor enzymatic activity. See Ref. [4b].
9. H. C. Brown, K. S. Bhat, J. Am. Chem. Soc. 1986, 108, 5919-5923;
10. for recent reviews, see: M. Lei, M. P. Sibi, Tetrahedron 2002, 58, 7991-8035, and references therein.
11. Experimental procedures and spectroscopic data can be found in the Supporting Information.
12. The acetylation was necessary for purification purposes.
13. The enantiomeric excess of compound 11 was evaluated by Mosher ester analysis of the alcohol resulting from acetate hydrolysis (see Supporting Information).
14. A. B. Benowitz, S. Fidanze, P. L. C. Small, Y. Kishi, J. Am. Chem. Soc. 2001, 123, 5128-5129.
15. D. R. Williams, K. Shamim, J. P. Reddy, G. S. Amato, S. M. Shaw, Org. Lett. 2003, 5, 3361-3364.
16. Compound 20 was easily prepared from commercially available ethyl 4-bromobutyrate.
17. K. Uwai, K. Ohashi, Y. Takaya, T. Ohta, T. Tadano, K. Kisara, K. Shibusawa, R. Sakakibara, Y. Oshima, J. Med. Chem. 2000, 43, 4508-4515.
18. M. Zhao, J. Li, E. Mano, Z. Song, D. M. Tschaen, E. J. J. Grabowski, P. J. Reider, J. Org. Chem. 1999, 64, 2564-2566; the oxidation reaction on 24 proved to be capriciously batch-dependant. It is reported therein that the presence of carbon-carbon double bonds can be troublesome. Two-step procedures (from the alcohol to the aldehyde and from the aldehyde to the carboxylic acid) gave yields of less than 30%. Fewer problems were observed for the oxidation of 30 (Scheme 5).
19. M. P. Glenn, M. J. Kelso, J. T. A. Tyndall, D. P. Fairlie, J. Am. Chem. Soc. 2003, 125, 640-641.
20. For recent reviews on peptide cyclizations, see: a) J. W. Davies, J. Pept. Sci. 2003, 9, 471-501;
21. b) P. Li, P. P. Roller, J. Xu, Curr. Org. Chem. 2002, 6, 411-440, and references therein.
22. a) S. Chen, J. Xu, Tetrahedron Lett. 1991, 32, 6711-6714;
23. b) J. Dudash, Jr., J. Jiang, S. C. Mayer, M. M. Joullie, Synth. Commun. 1993, 23, 349-356.
24. In the macrolactamization reaction, the reagents DPPA (the successor of the conventional "azide" coupling methods) and FDPP (inducing the formation of an activated pentafluorophenyl ester) are preferred to carbodiimide-based coupling reagents, whose urea group is difficult to remove (the only exception is the water soluble carbodiimide, EDC), and to "uronium" activators (for the concurrent end-capping through tetramethylguanidylation of the amino group).
25. Using DPPA and BOP-Cl [bis(2-oxo-3-oxazolidinyl)phosphinic chloride (see: C. van der Auwera, M. J. O. Anteunis, Int. J. Pept. Protein Res. 1987, 29, 574-588), we observed the formation of trace amounts (ESI-MS analysis) of the cyclotetrapeptide 34 (see Supporting Information).
26. 3OD solutions (see Supporting Information).